Christopher J. Ferreri

Statistics

Publications

Citations

768

H-Index

Active since

2022

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Levine Cancer Institute

Moffitt Cancer Center

Stanford University

Huntsman Cancer Institute

Christopher J. Ferreri is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, clinical trials, and cancer research.

ORCID

Top concepts

MedicineOncologyHematologyImmunologyImmunotherapyCancer ResearchClinical TrialsCancer TherapyPharmacotherapyHealth

Publications per year

2022–2025

Publications

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 257 citations · Full text

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 96 citations · Full text

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 92 citations · Full text

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

Surbhi Sidana, Lauren C. Peres, Hamza Hashmi et al. · Haematologica · 2023 · 36 citations · Full text

Mechanisms and management of CAR T toxicity

Christopher J. Ferreri, Manisha Bhutani · Frontiers in Oncology · 2024 · 35 citations · Full text

Immunology, Immunotherapy, Hematological Malignancy +16

1–5 of 18